- Home
- ZBIO vs CRNC Comparison
ZBIO vs CRNC Comparison
Compare ZBIO & CRNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBIO
- CRNC
- Stock Information
- Founded
- ZBIO 2019
- CRNC 2020
- Country
- ZBIO United States
- CRNC United States
- Employees
- ZBIO N/A
- CRNC N/A
- Industry
- ZBIO
- CRNC EDP Services
- Sector
- ZBIO
- CRNC Technology
- Exchange
- ZBIO NYSE
- CRNC Nasdaq
- Market Cap
- ZBIO 389.2M
- CRNC 445.8M
- IPO Year
- ZBIO 2024
- CRNC N/A
- Fundamental
- Price
- ZBIO $9.81
- CRNC $7.80
- Analyst Decision
- ZBIO Strong Buy
- CRNC Buy
- Analyst Count
- ZBIO 7
- CRNC 8
- Target Price
- ZBIO $32.29
- CRNC $8.41
- AVG Volume (30 Days)
- ZBIO 260.1K
- CRNC 1.1M
- Earning Date
- ZBIO 05-16-2025
- CRNC 05-07-2025
- Dividend Yield
- ZBIO N/A
- CRNC N/A
- EPS Growth
- ZBIO N/A
- CRNC N/A
- EPS
- ZBIO N/A
- CRNC N/A
- Revenue
- ZBIO $5,000,000.00
- CRNC $244,065,000.00
- Revenue This Year
- ZBIO N/A
- CRNC N/A
- Revenue Next Year
- ZBIO N/A
- CRNC $9.23
- P/E Ratio
- ZBIO N/A
- CRNC N/A
- Revenue Growth
- ZBIO N/A
- CRNC N/A
- 52 Week Low
- ZBIO $5.83
- CRNC $2.34
- 52 Week High
- ZBIO $26.25
- CRNC $27.50
- Technical
- Relative Strength Index (RSI)
- ZBIO N/A
- CRNC 42.06
- Support Level
- ZBIO N/A
- CRNC $6.96
- Resistance Level
- ZBIO N/A
- CRNC $7.65
- Average True Range (ATR)
- ZBIO 0.00
- CRNC 0.74
- MACD
- ZBIO 0.00
- CRNC 0.12
- Stochastic Oscillator
- ZBIO 0.00
- CRNC 59.65
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
About CRNC Cerence Inc.
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.